Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 27 (KRT8P27)
- Target
- KRT8P27
- Molecular classification
- Pseudogene, Type II keratin pseudogene, Intermediate filament pseudogene
01
Overview
Keratin 8 pseudogene 27 (KRT8P27) is one of many processed pseudogenes derived from the Keratin 8 (KRT8) gene, itself a member of the type II intermediate filament protein family. KRT8P27 does not encode a functional protein, lacks documented biological or pathological roles, and is classified as a non-coding, non-functional segment of genomic DNA. The high number of KRT8 and KRT18 pseudogenes present in the human genome reflects historical duplication and retrotransposition events, but these pseudogenes have not been shown to contribute to cellular function or disease in humans[2][3][7]. Key distinction: Keratin 8 (KRT8) encodes a functional protein with clinical relevance in cancer biology and diagnostics[1][5], but KRT8P27 is one of its processed pseudogenes and should not be considered a molecular target for therapeutic intervention.
- Other names
- KRT8P27keratin 8 pseudogene 27
02
Mechanism of action
None — there are no mechanisms of action associated with drugs targeting pseudogenes
03
Biological functions
No known biological function; pseudogenes do not encode functional proteins
04
Disease associations
No established role in disease; pseudogenes are generally considered nonfunctional and are not implicated in pathology except in rare regulatory or mutational contexts
05
Safety considerations
None — no safety concerns are reported or relevant for a pseudogene
06
Interacting drugs
None — no known drugs target this pseudogene
07
Biomarkers
None — KRT8P27 is not used as a biomarker for patient selection or efficacy monitoring
Beyond the preview
Go deeper on Keratin 8 pseudogene 27 (KRT8P27).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keratin 8 pseudogene 27 (KRT8P27).